Skip to content
10-Q

Quarterly Report

GLOBUS MEDICAL, INC. GMED

0001237831-25-000031

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 133.84M sh
Shares Diluted Q3 2025 · Sep 30, 2025 135.39M sh
Shares Diluted Q3 2025 · Sep 30, 2025 137.22M sh
Shares Diluted Q3 2025 · Sep 30, 2024 138.06M sh
Shares Diluted Q3 2025 · Sep 30, 2024 137.25M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $255.45M
Stock Repurchased Q3 2025 · Sep 30, 2024 $84.79M
Capex Q3 2025 · Sep 30, 2025 $118.48M
Capex Q3 2025 · Sep 30, 2024 $98.32M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $504.86M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $310.3M
Stockholders Equity Q3 2025 · Sep 30, 2025 $4.4B
Stockholders Equity Q3 2025 · Jun 30, 2025 $4.3B
Stockholders Equity Q3 2025 · Mar 31, 2025 $4.09B
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.18B
Stockholders Equity Q3 2025 · Sep 30, 2024 $4.07B
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.98B
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.92B
Stockholders Equity Q3 2025 · Dec 31, 2023 $4B
Current Liabilities Q3 2025 · Sep 30, 2025 $465.96M
Current Liabilities Q3 2025 · Dec 31, 2024 $855.91M
Total Liabilities Q3 2025 · Sep 30, 2025 $696.82M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.07B
Current Assets Q3 2025 · Sep 30, 2025 $1.92B
Current Assets Q3 2025 · Dec 31, 2024 $2.18B
Total Assets Q3 2025 · Sep 30, 2025 $5.1B
Total Assets Q3 2025 · Dec 31, 2024 $5.25B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.88
Eps Diluted Q3 2025 · Sep 30, 2025 $2.90
Eps Diluted Q3 2025 · Sep 30, 2024 $0.38
Eps Diluted Q3 2025 · Sep 30, 2024 $0.56
Eps Basic Q3 2025 · Sep 30, 2025 $0.88
Eps Basic Q3 2025 · Sep 30, 2025 $2.93
Eps Basic Q3 2025 · Sep 30, 2024 $0.38
Eps Basic Q3 2025 · Sep 30, 2024 $0.56
Sga Expense Q3 2025 · Sep 30, 2025 $313.6M
Sga Expense Q3 2025 · Sep 30, 2025 $860.02M
Sga Expense restated Q3 2025 · Sep 30, 2024 $240.06M
Sga Expense restated Q3 2025 · Sep 30, 2024 $728.2M
Rd Expense Q3 2025 · Sep 30, 2025 $38.07M
Rd Expense Q3 2025 · Sep 30, 2025 $111.08M
Rd Expense Q3 2025 · Sep 30, 2024 $35.38M
Rd Expense Q3 2025 · Sep 30, 2024 $130.35M
Net Income Q3 2025 · Sep 30, 2025 $118.97M
Net Income Q3 2025 · Sep 30, 2025 $397.27M
Net Income Q3 2025 · Sep 30, 2024 $51.84M
Net Income Q3 2025 · Sep 30, 2024 $76.48M
Operating Income Q3 2025 · Sep 30, 2025 $137.36M
Operating Income Q3 2025 · Sep 30, 2025 $310.48M
Operating Income Q3 2025 · Sep 30, 2024 $48.1M
Operating Income Q3 2025 · Sep 30, 2024 $105.72M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $252.53M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $696.7M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $270.52M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $772.04M
Revenue Q3 2025 · Sep 30, 2025 $769.05M
Revenue Q3 2025 · Sep 30, 2025 $2.11B
Revenue Q3 2025 · Sep 30, 2024 $625.71M
Revenue Q3 2025 · Sep 30, 2024 $1.86B